460 related articles for article (PubMed ID: 11851881)
1. Topical peroxisome proliferator activated receptor-alpha activators reduce inflammation in irritant and allergic contact dermatitis models.
Sheu MY; Fowler AJ; Kao J; Schmuth M; Schoonjans K; Auwerx J; Fluhr JW; Man MQ; Elias PM; Feingold KR
J Invest Dermatol; 2002 Jan; 118(1):94-101. PubMed ID: 11851881
[TBL] [Abstract][Full Text] [Related]
2. Liver X receptor activators display anti-inflammatory activity in irritant and allergic contact dermatitis models: liver-X-receptor-specific inhibition of inflammation and primary cytokine production.
Fowler AJ; Sheu MY; Schmuth M; Kao J; Fluhr JW; Rhein L; Collins JL; Willson TM; Mangelsdorf DJ; Elias PM; Feingold KR
J Invest Dermatol; 2003 Feb; 120(2):246-55. PubMed ID: 12542530
[TBL] [Abstract][Full Text] [Related]
3. Activators of peroxisome proliferator-activated receptors protect human skin from ultraviolet-B-light-induced inflammation.
Kippenberger S; Loitsch SM; Grundmann-Kollmann M; Simon S; Dang TA; Hardt-Weinelt K; Kaufmann R; Bernd A
J Invest Dermatol; 2001 Dec; 117(6):1430-6. PubMed ID: 11886504
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome-proliferator-activated receptor (PPAR)-gamma activation stimulates keratinocyte differentiation.
Mao-Qiang M; Fowler AJ; Schmuth M; Lau P; Chang S; Brown BE; Moser AH; Michalik L; Desvergne B; Wahli W; Li M; Metzger D; Chambon PH; Elias PM; Feingold KR
J Invest Dermatol; 2004 Aug; 123(2):305-12. PubMed ID: 15245430
[TBL] [Abstract][Full Text] [Related]
5. Topical application of silymarin reduces chemical-induced irritant contact dermatitis in BALB/c mice.
Han MH; Yoon WK; Lee H; Han SB; Lee K; Park SK; Yang KH; Kim HM; Kang JS
Int Immunopharmacol; 2007 Dec; 7(13):1651-8. PubMed ID: 17996674
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate.
Peters JM; Zhou YC; Ram PA; Lee SS; Gonzalez FJ; Waxman DJ
Mol Pharmacol; 1996 Jul; 50(1):67-74. PubMed ID: 8700121
[TBL] [Abstract][Full Text] [Related]
7. Agonists of peroxisome-proliferator activated receptor-alpha (clofibrate and WY14643) reduce renal ischemia/reperfusion injury in the rat.
Sivarajah A; Chatterjee PK; Hattori Y; Brown PA; Stewart KN; Todorovic Z; Mota-Filipe H; Thiemermann C
Med Sci Monit; 2002 Dec; 8(12):BR532-9. PubMed ID: 12503032
[TBL] [Abstract][Full Text] [Related]
8. Topical application of a novel immunomodulatory peptide, RDP58, reduces skin inflammation in the phorbol ester-induced dermatitis model.
De Vry CG; Valdez M; Lazarov M; Muhr E; Buelow R; Fong T; Iyer S
J Invest Dermatol; 2005 Sep; 125(3):473-81. PubMed ID: 16117788
[TBL] [Abstract][Full Text] [Related]
9. Fetal epidermal differentiation and barrier development In vivo is accelerated by nuclear hormone receptor activators.
Hanley K; Kömüves LG; Bass NM; He SS; Jiang Y; Crumrine D; Appel R; Friedman M; Bettencourt J; Min K; Elias PM; Williams ML; Feingold KR
J Invest Dermatol; 1999 Nov; 113(5):788-95. PubMed ID: 10571735
[TBL] [Abstract][Full Text] [Related]
10. Pseudoceramide stimulates peroxisome proliferator-activated receptor-α expression in a murine model of atopic dermatitis: molecular basis underlying the anti-inflammatory effect and the preventive effect against steroid-induced barrier impairment.
Lee SE; Jung MK; Oh SJ; Jeong SK; Lee SH
Arch Dermatol Res; 2015 Nov; 307(9):781-92. PubMed ID: 26121942
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses.
Berg DJ; Leach MW; Kühn R; Rajewsky K; Müller W; Davidson NJ; Rennick D
J Exp Med; 1995 Jul; 182(1):99-108. PubMed ID: 7790826
[TBL] [Abstract][Full Text] [Related]
12. Topical administration of the pan-Src kinase inhibitors, dasatinib and LCB 03-0110, prevents allergic contact dermatitis in mice.
Jung SH; Sun X; Ryu WS; Yang BS
Br J Dermatol; 2013 Jan; 168(1):112-9. PubMed ID: 23020072
[TBL] [Abstract][Full Text] [Related]
13. MDP(Lysyl)GDP, a nontoxic muramyl dipeptide derivative, inhibits cytokine production by activated macrophages and protects mice from phorbol ester- and oxazolone-induced inflammation.
Zunic M; Bahr GM; Mudde GC; Meingassner JG; Lam C
J Invest Dermatol; 1998 Jul; 111(1):77-82. PubMed ID: 9665390
[TBL] [Abstract][Full Text] [Related]
14. Murine atopic dermatitis responds to peroxisome proliferator-activated receptors alpha and beta/delta (but not gamma) and liver X receptor activators.
Hatano Y; Man MQ; Uchida Y; Crumrine D; Mauro TM; Feingold KR; Elias PM; Holleran WM
J Allergy Clin Immunol; 2010 Jan; 125(1):160-9.e1-5. PubMed ID: 19818482
[TBL] [Abstract][Full Text] [Related]
15. Co-treatment with retinyl retinoate and a PPARα agonist reduces retinoid dermatitis.
Kim B; Kim JE; Kim H; Lee JD; Choi KY; Lee SH
Int J Dermatol; 2012 Jun; 51(6):733-41. PubMed ID: 22607296
[TBL] [Abstract][Full Text] [Related]
16. Agonists of peroxisome proliferator-activated receptor gamma inhibit cell growth in malignant melanoma.
Mössner R; Schulz U; Krüger U; Middel P; Schinner S; Füzesi L; Neumann C; Reich K
J Invest Dermatol; 2002 Sep; 119(3):576-82. PubMed ID: 12230498
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor alpha regulates skin inflammation and humoral response in atopic dermatitis.
Staumont-Sallé D; Abboud G; Brénuchon C; Kanda A; Roumier T; Lavogiez C; Fleury S; Rémy P; Papin JP; Bertrand-Michel J; Tercé F; Staels B; Delaporte E; Capron M; Dombrowicz D
J Allergy Clin Immunol; 2008 Apr; 121(4):962-8.e6. PubMed ID: 18249437
[TBL] [Abstract][Full Text] [Related]
18. Topically applied diterpenoids from Egletes viscosa (Asteraceae) attenuate the dermal inflammation in mouse ear induced by tetradecanoylphorbol 13-acetate- and oxazolone.
Calou IB; Sousa DI; Cunha GM; Brito GA; Silveira ER; Rao VS; Santos FA
Biol Pharm Bull; 2008 Aug; 31(8):1511-6. PubMed ID: 18670081
[TBL] [Abstract][Full Text] [Related]
19. Activation of peroxisome proliferator-activated receptor gamma does not inhibit IL-6 or TNF-alpha responses of macrophages to lipopolysaccharide in vitro or in vivo.
Thieringer R; Fenyk-Melody JE; Le Grand CB; Shelton BA; Detmers PA; Somers EP; Carbin L; Moller DE; Wright SD; Berger J
J Immunol; 2000 Jan; 164(2):1046-54. PubMed ID: 10623855
[TBL] [Abstract][Full Text] [Related]
20. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
